Form 4: Tela Bio Executive Paul Talmo Reports Stock Transaction
SEC Form 4 Filing
Chief Technology Officer Paul Talmo of Tela Bio, Inc. reports a transaction involving common stock to cover withholding taxes.
Summary
- On March 31, 2025, Paul Talmo, Chief Technology Officer of TELA Bio, Inc., reported a transaction involving the company's common stock.
- The transaction involved the withholding of 190 shares to satisfy applicable withholding taxes upon the vesting of restricted stock units at a price of $1.22.
- Following the transaction, Talmo directly owns 123,882 shares of TELA Bio, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine transaction. It doesn't indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard transaction related to tax obligations upon vesting of stock units.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related activity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the stock transaction |
| 04/02/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, TELA Bio, Stock Transaction, Beneficial Ownership, Paul Talmo, Chief Technology Officer, Withholding Taxes, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.